Mutualism between insects and symbiotic bacteria drives insect evolution, and insecticide resistance is affected by symbiotic bacteria, increasing the complexity of pest resistance. This study evaluated the sublethal and transgenerational effects of the neonicotinoid insecticide nitenpyram on the population dynamics of Acyrthosiphon gossypii and measured its impact on the symbiotic bacterial community. The results showed that LC20 (2.49 mg·L−1) of nitenpyram significantly reduced the fecundity and lifespan of the parent G0 generation of A. gossypii, and had similar inhibitory effects on its G1 and G2 generations. Compared with those of control group, the population parameters λ (finite rate of increase), R0 (net reproductive rate), and r (intrinsic increase rate) of G1 and G2 were significantly reduced, but mean generation time (T) was increased. Nitenpyram treatment affected the biological traits of A. gossypii, and also changed the relative abundance of Buchnera and Sphingomonas in three consecutive generations G0-G2. Under nitenpyram treatment, the relative abundance of Buchnera decreased in G0, while that of Sphingomonas increased. The relative abundance of Buchnera increased in G1 and G2, but that of Sphingomonas decreased. Our findings may provide a new perspective for evaluating the potential effects of pesticides on aphids.

Mutualism between insects and symbiotic bacteria drives insect evolution, and insecticide resistance is affected by symbiotic bacteria, increasing the complexity of pest resistance. This study evaluated the sublethal and transgenerational effects of the neonicotinoid insecticide nitenpyram on the population dynamics of Acyrthosiphon gossypii and measured its impact on the symbiotic bacterial community. The results showed that LC20 (2.49 mg·L−1) of nitenpyram significantly reduced the fecundity and lifespan of the parent G0 generation of A. gossypii, and had similar inhibitory effects on its G1 and G2 generations. Compared with those of control group, the population parameters λ (finite rate of increase), R0 (net re-productive rate), and r (intrinsic increase rate) of G1 and G2 were significantly reduced, but mean gen-eration time (T) was increased. Nitenpyram treatment affected the biological traits of A. gossypii, and also changed the relative abundance of Buchnera and Sphingomonas in three consecutive generations G0-G2. Under nitenpyram treatment, the relative abundance of Buchnera decreased in G0, while that of Sphin-gomonas increased. The relative abundance of Buchnera increased in G1 and G2, but that of Sphingo-monas decreased. Our findings may provide a new perspective for evaluating the potential effects of pesticides on aphids.

{This study investigates the coordinated behaviors and the underlying collective intelligence in biological groups, particularly those led by informed leaders. By establishing new convergence criteria based on real biological group experiments, this research introduces the concept of a volitional term and heterogeneous networks, constructing a coupled force Cucker-Smale model with informed leaders. The inclusion of the informed leader aspect distinctively characterizes the dynamics of leaders and followers, enabling a more accurate representation of biological group behavior. The paper then proposes the Flock Leadership Hierarchy Network (FLH), a model reflecting real biological interactions. By employing time slicing and rolling time windows, the study methodically analyses group behavior stages, using volatility and convergence time as metrics to examine the relationship between group consistency and interactions. Comparative experiments show the FLH network's superior performance. The Kolmogorov-Smirnov test indicates that the FLH network follows a power-law distribution, highlighting the evolutionary intelligence of biological groups. This research offers new perspectives on the evolution of biological groups, contributing to our understanding of both natural and artificial systems, such as animal migration and autonomous drone operations.

Antibacterial bone cements (ABCs), such as antibiotic-loaded bone cements (ALBCs), have been widely utilized in clinical treatments. Currently, bone cements loaded with vancomycin, gentamicin, tobramycin, or clindamycin are approved by the US Food and Drug Administration. However, traditional ALBCs exhibit drawbacks like burst release and bacterial resistance. Therefore, there is a demand for the development of antibacterial bone cements containing novel agents. In this review, we summarize the latest advancements in ABCs. More importantly, we provide an overview and outlook on novel antibacterial agent-loaded bone cements, including metallic antibacterial agents, pH-switchable antibacterial agents, cationic polymers, N-halamines, non-leaching acrylic monomers, antimicrobial peptides, etc. Offering novel perspectives for designing ABCs and treating bone infections.